Pricing Log in Create free account

Alvotech (ALVO) vs HUTCHMED (China) Limited Sponsored ADR (HCM)

Alvotech and HUTCHMED (China) Limited Sponsored ADR are both Drug Manufacturers Specialty & Generic companies. HUTCHMED (China) Limited Sponsored ADR is the larger, with a market value of $2.4B against $2.1B — 1.2× the size. Alvotech grew revenue faster over the last twelve months: 364.3% against 245.2%. HUTCHMED (China) Limited Sponsored ADR has the higher net margin (−23.6% vs −101.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, HUTCHMED (China) Limited Sponsored ADR leads on 8 and Alvotech on 3.

Valuation

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 5.02 n/m 2.11
P/B n/m n/m 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m 0.38 12.58
EV/Sales 8.98 (0.13) 2.73
Earnings yield (23.93%) (20.94%) (4.38%)
Free cash flow yield (14.39%) 0.00% 0.00%

Profitability

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
Gross margin 42.71% 44.40% 53.94%
Operating margin (42.43%) 0.00% 0.00%
Net margin (101.05%) (23.63%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.40%)
Return on assets 0.00% 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 364.29% 245.17% 10.01%
EPS growth (last fiscal year) 111.49% 1,090.91% 49.06%
Revenue growth, 5-year CAGR — 19.20% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
Debt to equity (6.82) 0.07 0.05
Current ratio 1.65 5.64 2.31
Net debt to EBITDA 9.71 49.29 0.97

Dividend

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
Market cap 2.07b 2.43b 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack